✦ LIBER ✦

PIN72 Cost-Effectiveness Analysis of Palivizumab With Risk Factors for Respiratory Syncytial Virus Prevention

✍ Scribed by M.Y. Lee; E.K. Lee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of respiratory syncyt

✍ Carole A Reeve; John S Whitehall; Petra G Buettner; Robert Norton; David M Reeve 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PIN35 COST-EFFECTIVENESS ANALYSIS OF PAL

✍ S Ikeda; M Kobayashi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Palivizumab for respiratory syncytial vi

✍ Jennifer H. Lofland; Suzanne M. Touch; John P. O'Connor; Mary Lou Chatterton; El 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 890 KB

PIN38 COST-EFFECTIVENESS ANALYSIS OF PAL

✍ Kang, HY; Kim, HS; Choi, JY; Kim, YH 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Cost-effectiveness analysis of palivizum

✍ Kristian Neovius; Katharina Buesch; Kristina Sandström; Martin Neovius 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB

PIN24 COST-EFFECTIVENESS OF RESPIRATORY

✍ L.B. Weiner; M.J. Polak; A. Masaquel; P.J. Mahadevia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB